BRCA1 and ovarian cancer: Although BRCA1-Δ11q alternative splice isoform has been shown to contribute to cisplatin-resistance in ovarian cancer, the alternative splicing rate or BRCA1-Δ11q level was not altered by frameshift mutations in exon 11-induced NMD or its containing-transcripts.